XAGE Valuation

Longevity Health Holdings Inc

Add to Watchlist

Advanced Chart

2.540

+0.02(0.794%)1D

Overview
Forecast
Valuation
Earnings

XAGE Relative Valuation

XAGE's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, XAGE is overvalued; if below, it's undervalued.

Historical Valuation

Longevity Health Holdings Inc (XAGE) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of 0.00. The fair price of Longevity Health Holdings Inc (XAGE) is between to according to relative valuation methord.

Relative Value

Fair Zone

Current Price：2.52

Fair

0.00

Trailing

Forward

0.00

EV/EBITDA

Longevity Health Holdings Inc. (XAGE) has a current EV/EBITDA of 0.00. The 5-year average EV/EBITDA is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward EV/EBITDA of 0.00 falls within the Strongly Undervalued range.

0.00

EV/EBIT

Longevity Health Holdings Inc. (XAGE) has a current EV/EBIT of 0.00. The 5-year average EV/EBIT is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward EV/EBIT of 0.00 falls within the Strongly Undervalued range.

0.00

Longevity Health Holdings Inc. (XAGE) has a current PS of 0.00. The 5-year average PS is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward PS of 0.00 falls within the Strongly Undervalued range.

0.00

P/OCF

Longevity Health Holdings Inc. (XAGE) has a current P/OCF of 0.00. The 5-year average P/OCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/OCF of 0.00 falls within the Strongly Undervalued range.

0.00

P/FCF

Longevity Health Holdings Inc. (XAGE) has a current P/FCF of 0.00. The 5-year average P/FCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/FCF of 0.00 falls within the Strongly Undervalued range.

Longevity Health Holdings Inc (XAGE) has a current Price-to-Book (P/B) ratio of -1.02. Compared to its 3-year average P/B ratio of -1.00 , the current P/B ratio is approximately 2.25% higher. Relative to its 5-year average P/B ratio of -1.00, the current P/B ratio is about 2.25% higher. Longevity Health Holdings Inc (XAGE) has a Forward Free Cash Flow (FCF) yield of approximately -86.22%. Compared to its 3-year average FCF yield of -97.49%, the current FCF yield is approximately -11.56% lower. Relative to its 5-year average FCF yield of -97.49% , the current FCF yield is about -11.56% lower.

-1.00

P/B

Median3y

-1.00

Median5y

-1.00

-81.88

FCF Yield

Median3y

-97.49

Median5y

-97.49

Competitors Valuation Multiple

The average P/S ratio for XAGE's competitors is 18.08, providing a benchmark for relative valuation. Longevity Health Holdings Inc Corp (XAGE) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of 3987.76%, this premium appears sustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

XAGE.O

Longevity Health Holdings Inc

New Era Energy & Digital Inc

Virax Biolabs Group Ltd

Freight Technologies Inc

Performance Decomposition

Market capitalization of XAGE decreased by 86.73% over the past 1 year. The primary factor behind the change was an increase in Revenue Growth from 12.32K to 503.61K.

The secondary factor is the Margin Expansion, contributed -98.60%to the performance.

Overall, the performance of XAGE in the past 1 year is driven by Revenue Growth. Which is more sustainable.

3987.76%

12.32K → 503.61K

Revenue Growth

-98.60%

-26.82K → -374.58

Margin Expansion

-3975.89%

0.01 → -0.32

P/E Change

-86.73%